30 November 2022

Last updated: Tuesday 29 November 2022

Drug discovery

Microbiome-based therapies as anti-cancer agents

Antibody-drug conjugates come to the fore

The microbiome and cancer

The lasting value of small molecule drugs

Therapeutic approaches to geographic atrophy

Cell therapy shows promise in pancreatic cancer

Drug discovery in the age of deep sequencing

Meeting the challenges of real-world data access

Meeting the need for better reproductive health

How a new CNS company was founded, then sold